Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
New GSK Investor update
Emma Walmsley, CEO, and other members of CET will host a virtual investor update at 14:00-17:30 BST on Wednesday 23 June. The update will provide a clear view of the strategy for New GSK, its outlook for growth and the opportunities we see for shareholder value creation.
Press releases for media
- ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra long-acting” medicines for HIV
- GSK and Vir Biotechnology announce continuing progress of the COMET clinical development programme for sotrovimab
- GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal antibody, enabling novel next-generation immuno-oncology combinations
- GSK to showcase scientific advances and progress in oncology at ASCO and EHA
GSK Twitter
-
GSK @GSK
After almost four decades, we’re continuing to work to find new ways to treat and prevent #HIV through our specialist company, @ViiVHC. Go #BehindTheScience to find out more about the challenge that was facing researchers in the early 1980s.
about 6 hours ago -
GSK @GSK
#News for #investors and #media: Today’s new collaboration announcement with Halozyme, Inc. keeps us at the forefront of developing innovative new options for HIV treatment and prevention. More information on gsk.com
about 9 hours ago
2021 First quarter results announcement
We announced our first quarter results for the period ended 31 March 2021 on Wednesday 28 April.
